Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
Silencing van het hepatitis B-virus S-gen door CRISPR‐gemedieerde base editing
feb 2020 | Hepatitis, Hepatologie, Virale infecties